Responses
Original research
Correlation of disability with quality of life in patients with multiple sclerosis treated with natalizumab: primary results and post hoc analysis of the TYSabri ImPROvement study (PROTYS)
Compose a Response to This Article
Other responses
No responses have been published for this article.